Telepsychotherapy for the Treatment of Adolescents With Trichotillomania

NCT03725163 | Unknown

• 1 other identifier: 9153
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The primary purpose of the current study is to evaluate the effectiveness of providing treatment for adolescents with trichotillomania through the use of telehealth. Parent or legal guardians' psychological flexibility scores will be assessed to determine if their levels of flexibility potentially moderate treatment outcomes. The study will test the following hypotheses: Hypothesis 1: Telepsychotherapy will result in significantly better trichotillomania symptom outcomes for adolescents than a waitlist control condition. Hypothesis 2: Telepsychotherapy will result in significantly better psychological flexibility outcomes for adolescents than a waitlist control condition. Hypothesis 3: Telepsychotherapy will result in significantly better overall wellbeing outcomes for adolescents than a waitlist control condition. Hypothesis 4: Within-group changes (that include both conditions following treatment) will be significant from pre-treatment to post-treatment and will not significantly differ from post-treatment at 3, 6, and 12-month follow-up.

Conditions

Trichotillomania

Keywords

Trichotillomania; Adolescents; Telepsychotherapy; AEBT; ACT

Outcome Measures

Primary Outcomes (3)

• Trichotillomania Scale for Children-Chile and Parent Versions (TSC-C & TSC-p)

  This self-report measure can be filled out by both the adolescent and parent. This measure is broke into 2 components: severity (5 items) and distress/impairment (7 items). A total of 3 scores are obtained, one for each component and a total score. This measure provides information about symptom severity and level of impairment or distress of trichotillomania for the client. Items 1-5 represent the severity score, each item is scored 0-2 with 2 representing higher severity. Items 1-5 are summed then divided by 5 to give a severity score. Items 6-12 represent the Distress/Impairment section and follow a similar scoring format summing each item and dividing by 7 to represent the Distress/Impairment score. The Severity Score and Distress/Impairment score are summed to give a total score. The minimum value for scores can be 0, with the highest score being 4 for the total score.

  Changes in scores from baseline, 10-week post-treatment, and 3-, 6-, and 12-month follow-ups will be assessed.

• Acceptance and Action Questionnaire for Trichotillomania (AAQ-TTM)

  This measure assesses a participant's overall levels of psychological inflexibility in relation to trichotillomania and how impairing trichotillomania may be for the individual. Each item ranges on scores from 1 (Never true) to 7 (always true). Higher scores on each item indicate higher levels of distress or psychologically inflexibility in relation to their trichotillomania. The values for each items are summed to provide a total score. Higher scores tend to indicate greater psychological flexibility. Items 2,3,4,5,7,8, and 9 are reversed scored.

  Changes in scores from baseline, 10-week post-treatment, and 3-, 6-, and 12-month follow-ups will be assessed.

• Warwick-Edinburgh Mental Well-being Scale (WEBWMS)

  This is a 14-item Likert-type scale that measures overall well-being for participants. Each item has scores ranging from 1="None of the time" to 5 "All of the time". Higher scores indicate higher levels of overall well-being for a client.

  Changes in scores from baseline, 10-week post-treatment, and 3-, 6-, and 12-month follow-ups will be assessed.

Secondary Outcomes (3)

• Acceptance and Fusion Questionnaire for Youth (AFQ-Y8)

  Changes in scores from baseline, 10-week post-treatment, and 3-, 6-, and 12-month follow-ups will be assessed.

• Youth Outcome Questionnaire (YOQ-C & YOQ-P)

  Changes in scores from baseline, 10-week post-treatment, and 3-, 6-, and 12-month follow-ups will be assessed.

• Parental Acceptance Questionnaire (6-PAQ)

  Changes in scores from baseline, 10-week post-treatment, and 3-, 6-, and 12-month follow-ups will be assessed.

Study Arms (2)

Treatment

EXPERIMENTAL

This arm will begin treatment immediately after completing the initial intake assessment.

Behavioral: Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT)

Waitlist Control

OTHER

Participants assigned to the waitlist control condition will begin a 12-week waiting period after completing the initial intake assessment before starting treatment.

Behavioral: Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT)

Interventions

Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT) BEHAVIORAL

This treatment approach blends traditional behavior therapy elements of habit reversal training and stimulus control techniques with the more contemporary behavioral elements of Acceptance and Commitment Therapy (ACT). The first phase of the treatment, clients are taught skills for stopping and preventing their unconscious pulling episodes. The second phase, clients are introduced to ACT. Unlike interventions that aim to change the type or frequency of pulling-related cognitions, this treatment uses strategies to change the function of these cognitions. Clients are taught to see urges for what they really are and to accept their pulling-related thoughts, feelings, and urges without fighting against them. Over the course of 10 session clients will learn to be aware of their pulling and warning signals, use self-management strategies for stopping and preventing pulling, stop fighting against their pulling-related urges and thoughts, and work toward increasing their quality of life.

Treatment; Waitlist Control

Eligibility Criteria

• Age: 12 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Meet DSM-5 criteria for trichotillomania.
• Seeking treatment primarily for trichotillomania-related concerns.
• years old.
• Reside in Utah.
• Speak fluent English.
• Parents:
• Must be fluent English speaker.

You may not qualify if:

• Currently receiving psychotherapy.
• Started or changed psychotropic medication in the past 30 days.
• Planning to start or change psychotropic medication during the course of the current study.
• Completed high school.

Sponsors & Collaborators

• Utah State University: lead

Study Sites (1)

Utah State University

Logan, Utah, 84322, United States

RECRUITING

MeSH Terms

Conditions

Trichotillomania

Condition Hierarchy (Ancestors)

Obsessive-Compulsive Disorder; Anxiety Disorders; Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders

Study Officials

• Michael P Twohig, PhD

  Utah State University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeremiah E Fruge, BA

CONTACT

435-797-8303; jeremiah.fruge@aggiemail.usu.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Model Details: Participants will be randomized using block randomization to be assigned to a waitlist control condition or the treatment condition. Participants assigned to the waitlist control will have a 12-week waiting period prior to starting treatment. Those assigned to the treatment condition will begin therapy immediately.

Study Record Dates

• First Submitted: October 15, 2018
• First Posted: October 30, 2018
• Study Start: August 6, 2018
• Primary Completion: August 5, 2020
• Study Completion: August 5, 2020
• Last Updated: October 30, 2018

Record last verified: 2018-10

Locations

US (1)